La Paz, 18 February 2022 (TDI): The United States has shipped new doses of Pfizer vaccines to the Plurinational State of Bolivia. The Vaccines arrived on February 16 to help Bolivia with the COVID-19 Pandemic.

The U.S. Embassy Charge d’Affaires Charisse Phillips shows felicitation on the arrival of a new batch of Pfizer vaccines. This Batch consists of 1,310,400 doses of the Pfizer vaccines.

The United States provided doses are all free of charge and also without any conditions. The free of charge and unconditional delivery of the vaccine is an expression of solidarity with Bolivia.

The donation is done through the project of COVAX. COVAX is a coalition between countries to provide covid -19 vaccines in the whole world, and specifically to middle and lower-income countries. The United state is the largest contributor in donating vaccines.

Furthermore, U.S. Embassy Charge d’Affaires Charisse Phillips said that the US will continue to support Bolivia and its efforts to revive the economy. Likewise, the U.S will help Bolivia to get out of the pandemic and to return to normal life sooner.

In total, the U.S delivered more than 4.5 million doses of vaccines to the Plurinational State of Bolivia.

U.S and Bolivia Relations

The Plurinational State of Bolivia got independence from Spain in 1825. While in 1849 United States established diplomatic relations with Bolivia. The two states work to advance human rights as well as entrepreneurship, cultural, and educational initiatives.

The two are members of similar international organizations. For instance, the United Nations(UN), the Organization of American States(OAS), the World trade organization(WTO), the World Health Organization (WHO), and more.

U.S-Bolivia and COVID-19

The United States helps Bolivian people to confront the COVID-19. The US delivered different tools to fight the pandemic, such as vaccines and economic help. For instance, The US gave approximately 7 million dollars for the Bolivian health sector.

This 7 million dollar was for capacity building in COVID-19 diagnosis and improving epidemic surveillance, as well as supporting COVID-19 response efforts for refugees and host communities.